There are currently over 200 conditions in the Compassionate Allowances program
SUSTAIN research study showed that in patients with type 2 diabetes at high cardiovascular risk, the rate of first occurrence of death from cardiovascular causes, nonfatal heart attack and stroke was significantly lower in those receiving Ozempic compared to those patients receiving placebo
Our team of experts along with our broad portfolio makes it easy to: Screen for inhibitors/targets using our GIP and cell-based assays Obtain IC 50 or EC 50 determination or single point concentrations of compound series Perform follow-up studies Get questions answered or project guidance in a time-efficient manner Save time and resources by skipping assay or cell line development
Short exposure within limits may be acceptable, but verify
Some commonly prescribed GLP-1 agonists include exenatide, liraglutide, dulaglutide, and semaglutide
Start Your Journey Toward Better Balance If you suffer from Mnire's disease and struggle with vertigo, Betahistine might be the right treatment for you